• 1
    Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1995: estimates based on data from nine population-based cancer registries. Jpn J Clin Oncol 2000; 30: 31821.
  • 2
    Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura MY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 181927.
  • 3
    Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 1973; 51: 147983.
  • 4
    MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst 1973; 50: 2142.
  • 5
    Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: SchottenfeldD, ed. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 102239.
  • 6
    Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7: 113344.
  • 7
    Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87: 6705.
  • 8
    Nordyke EC. The peopling of Hawaii. Honolulu: University of Hawaii Press, 1989.
  • 9
    American College of Radiology. Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology, 1993.
  • 10
    Maskarinec G, Meng L, Ursin G. Ethnic differences in mammographic densities. Int J Epidemiol 2001; 30: 95965.
  • 11
    Hawaii Department of Health. 2000 State of Hawaii behavioral risk factor surveillance system. Honolulu: Hawaii Department of Health, 2002. (
  • 12
    Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994; 39: 162938.
  • 13
    Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV. The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 1998; 7: 437.
  • 14
    Boyd NF, Wolfson C, Moskowitz M, Carlile T, Petitclerc C, Ferri HA, Fishell E, Gregoire A, Kiernan M, Longley JD, Simor IS, Miller AB. Observer variation in the classification of mammographic parenchymal patterns. J Chronic Dis 1986; 39: 46572.
  • 15
    Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 4208.
  • 16
    Armitage P. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1971.
  • 17
    Littell RC, Freund RJ, Spector PC. SAS system for linear models. Cary, NC: SAS Institute, 1991.
  • 18
    Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: an alternative to least squares means. Am Stat 1980; 34: 21621.
  • 19
    Kojima O, Majima T, Uehara Y, Ikeda E, Ahn T, Fujita Y, Tamura Y, Majima S. Radiographic parenchymal patterns in Japanese females as a risk factor for breast carcinoma. World J Surg 1984; 8: 4148.
  • 20
    Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 1976; 126: 11309.
  • 21
    Gravelle IH, Bulbrook RD, Wang DY, Alen D, Hayward JL, Bulstrode JC, Takatani O. A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Res Treat 1991; 18: S935.
  • 22
    Morimoto T, Sasa M, Tamaguchi T, Kondo H, Sagara Y, Kuwamura Y, Yamamoto S, Tada T. Effectiveness of mammographic screening for breast cancer in women aged over 50 years in Japan. Jpn J Cancer Res 1997; 88: 77884.
  • 23
    Maskarinec G, Meng L, Shimozuma K. A pilot study of mammographic density patterns among Japanese women. J Epidemiol 1999; 9: 737.
  • 24
    Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G. Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis 2001; 11: 4450.
  • 25
    MacMahon B, Cole P. Oestrogen profiles of Asian and North American women. Lancet 1971; ii: 9002.
  • 26
    Bulbrook RD, Swain MC, Wang DY, Hauward JL, Kumaoka S, Takatani O, Abe O, Utsunomiya J. Breast cancer in Britain and Japan: plasma oestradiol-17beta, oestrone and progesterone, and their urinary metabolites in normal British and Japanese women. Eur J Cancer 1976; 12: 72535.
  • 27
    Shimizu H, Ross RK, Bernstein L, Pike M, Henderson BE. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 1990; 62: 4513.
  • 28
    Ursin G, Wilson M, Henderson BE, Kolonel LN, Monroe K, Lee HP, Seow A, Yu MC, Stanczyk FZ, Gentzschein E. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and white women? Cancer Res 2001; 61: 33269.
  • 29
    Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174: 48790.
  • 30
    Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 4337.
  • 31
    Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E. Effects of estrogen and estrogen–progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) investigators. Ann Intern Med 1999; 130: 2629.
  • 32
    Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994; 86: 4316.
  • 33
    Gram IT, Ursin G, Spicer DV, Pike MC. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer Epidemiol Biomarkers Prev 2001; 10: 111720.
  • 34
    Atkinson C, Warren R, Bingham SA, Day NE. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev 1999; 8: 8636.
  • 35
    Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2000; 9: 9115.
  • 36
    Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J. Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 2000; 9: 91721.
  • 37
    Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000; 60: 37448.
  • 38
    Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996; 7: 60525.
  • 39
    Morrison AS. Screening in chronic disease. New York: Oxford University Press, 1992.
  • 40
    Wakai K, Suzuki S, Ohno Y, Kawamura T, Tamakoshi A, Aoki R. Epidemiology of breast cancer in Japan. Int J Epidemiol 1995; 24: 28591.
  • 41
    Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87: 16229.